PCVX Financials

Vaxcyte Inc - Financial statements & key metrics

Stock Price

$62.35

Market Cap

$9.03B

EPS

$-5.63

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

Gross Profit

Operating Income

Net Income

$-463.93M

EPS (Diluted)

$-3.80

Balance Sheet Highlights

Total Assets

$3.51B

Total Liabilities

$205.50M

Shareholders Equity

Cash & Equivalents

$387.88M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-452.63M

CapEx

Free Cash Flow

Profitability Metrics

ROE

-0.3%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is PCVX revenue?

View PCVX's income statement for detailed revenue data.

Is PCVX profitable?

PCVX reported a loss of $463.93M in the most recent quarter.

What is PCVX market cap?

PCVX has a market capitalization of $9.03B, making it a mid-cap stock.

Does PCVX have debt?

View PCVX's balance sheet for debt information.

What is PCVX cash flow?

Cash flow data is available in the full financial statements.